Adapt Pharma

5 results

Ireland’s industry superstars give cause for optimism.

Talk about pharma and medtech in Ireland and the presumption is always that the conversation relates to multinational giants, tax breaks and governmen(...)

Adapt Pharma developed a non-injectable form of Naloxone,  which resulted in a $735 million payday for its investors,  including serial pharmaceutical entrepreneur Séamus Mulligan

You’d never say that a $735 million payday was not a landmark occasion but the sale of Adapt Pharma – the maker of the opioid rescue drug Narcan that (...)

Two members of the Manchester fire department in New Hampshire assess the condition of a man who had overdosed on heroin and who was revived with two doses of Narcan. Photograph: Don Emmert/AFP/Getty Images

In hindsight, it looks like a no-brainer. Take a tried and tested drug that addresses a burgeoning epidemic and make it easier to use. Then sit back a(...)

An overdose rescue kit featuring nasal spray and injectable Naloxone at a demonstration in New York. File photograph: Getty Images

Six Irish businessmen will share a $635 million (€542m) payday after selling a company that developed a drug used in the frontline as the United State(...)

A man administers Adapt Pharma’s Narcan as they try to revive a man who overdosed on heroin in Philadelphia. The man later came to and was taken to the hospital. Photograph:  Spencer Platt/Getty Images

Adapt Pharma, the Irish company behind emergency overdose treatment Narcan, has been sold in a $635 million deal. The Irish shareholders of the busin(...)